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RETROPERITONEAL LAPAROSCOPIC RESECTION OF NEUROGENIC
TUMOR
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Purpose: Retroperitoneal laparoscopic resection of retroperitoneal tumor
can be challenging due to variations in location, size, and tumor charac-
teristics. We would like to share our experience in retroperitoneoscopic
surgery for neurogenic tumor and the experience of using intra-operative
neuromonitoring technique.
Materials and Methods: Between June 2014 and December 2015, retro-
peritoneal laparoscopic resection of retroperitoneal tumor was performed
on 10 patients. Three of the 10 patients were pathologically proved
Shwannoma. Others include metastatic malignant melanoma, leiomyo-
sarcoma, liposarcoma, cystic lymphangioma, hemangioma, adrenal
cortical carcinoma, and pheochromocytoma. Among three patient with
Shwannoma, intraoperative neuromonitoring was used in two patients for
pre-operative image suggest possible neurogenic tumor. One patient un-
derwent resection of two tumors at the same time.
Results: Themedian tumor diameterwas 6.75 cm (range 4e12). The tumor
location: two embedded on right psoas muscle with right L3 root
compression, one at lower pole of right kidney with right psoas muscle
adhesion, one at retrocaval region. All of the tumors were approached
retroperitoneally. The median operative time was 206 min (range
120e300) and blood loss was 33 mL (range 0e100). No patient required
blood transfusion. One patient receiving robotic assisted surgery had a
conversion to traditional laparoscopic surgery because of malposition of
the robot. Pathological examination revealed all schwannoma in 3 cases.
During follow-up, there was no tumor recurrence noted.
Conclusion: Retroperitoneal laparoscopic resection of neurogenic tumor is
a feasible choice. Combining intraoperative neuromoitoring, we can
decrease the risk of neurological complication. When dealing with tumor
next to great vessel or location hard to approach, pre-operative planning is
necessary.
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MULTILOCULAR CYSTIC NEPHROMA: A CASE REPORT AND REVIEW OF
THE LITERATURE
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Cystic nephroma is a relative rare benign renal lesion with a bimodal age
distribution. Diagnostic peaks occur primarily in the ﬁrst 2 to 3 years of
life, and again in the forty to ﬁfty years. They are usually incidentally
found as an asymptomatic abdominal mass. Radiologically, it is difﬁcult
to differentiate between cystic nephroma and cystic RCC in adults. The
exact diagnosis primarily depends on the histopathologic examination.
We present a 28 year-old male patient with a symptomatic, incidentally
found left complicated renal cyst. A laparoscopic partial nephrectomy
was performed on this patient. Microscopically, the tumor composed of
variable-sized cysts lined by a layer of ﬂattened or cuboidal cells with a
conﬁrmed histological diagnosis of cystic nephroma. The literatures were
reviewed.
NDP024:
METANEPHRIC ADENOMA OF THE KIDNEY e A CASE REPORT AND
LITERATURE REVIEW
Chia-Hung Chen 1, Yen-Hua Chang 1,2,3, Alex Tong-Long Lin 1,2,3, Kuang-
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National Yang-Ming University, Taiwan; 2 School of Medicine, National
Yang-Ming University, Taiwan; 3 Shu-Tien Urological Institute, National
Yang-Ming University, TaiwanPurpose: Metanephric adenoma (MA) is a rare neoplasm. It’s benign renal
neoplasm originating in the epithelial cells of the kidney. Most tumors are
asymptomatic, and incidentally discovered during examinations for other
problems. It is difﬁcult to distinguish metanephric adenoma from malig-
nant neoplasms by image. It is often diagnosed by pathological report after
surgical treatment. The present study reports the case of a 45-year-old
female that presented with metanephric adenoma.
Materials and Methods: A 45 years-old female had small renal mass over
left kidney during evaluation of pancreas mass. Physical examination
revealed no signiﬁcant ﬁnding. Computerized tomography (CT) and
Magnetic resonance imaging (MRI) revealed a neoplasm lesion localized in
the left kidney without lymphadenopathy. Left partial nephrectomy was
performed on December 23, 2015. Microscopic ﬁnding composed of
monotonous tumor cells with few light pink cytoplasm, small, uniform
nuclei and inconspicuous nucleoli, arranged in solid sheets, small acini,
and papillary structure. Hyalinized stroma with focal calciﬁcation are also
noted. The tumor cells are immunoreactive for Wilms' tumor antigen
(WT1). The ﬁnal pathological report revealed metanephric adenoma.
Results: According the literature review, Metanephric adenoma (MA) is a
rare benign tumor that accounts for 0.2e0.7% of adult renal epithelial
neoplasms. <200 cases have been reported in the literature. Peak age of
MA was in the ﬁfth or sixth decade of life. Most tumors are incidentally
ﬁnding. Some patient will have ﬂank pain, hematuria and palpable mass.
Lab data may reveal polycythemia. MA cannot be easily distinguished from
othermalignant neoplasms using imaging alone. Macroscopic, MA appears
as a well-deﬁned, round, solid, soft mass varying in size. Microscopic, MA
expresses CK7 andWT1 and does not express epithelial membrane antigen
or AMACR. Radical or partial nephrectomy may indicate for treatment due
to the risk of malignancy without pathology.
Conclusion: Metanephric adenoma is a rare benign tumor. It cannot be
easily distinguished from malignant neoplasms of kidney by imaging.
Metanephric adenoma can recognized by microscopy. Surgical interven-
tion is suggested due to diagnosis is challenging without pathology.
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PRIMARY LARGE CELL NEUROENDOCRINE CARCINOMA OF THE KIDNEY
WITH COEXISTING HIGH-GRADE UROTHELIAL CARCINOMA AND
VIRCHOW’S NODE METASTASIS: A CASE REPORT AND LITERATURE
REVIEW
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Primary large cell neuroendocrine carcinomas of the kidney are extremely
rare, and distant metastases are scarcely reported. Here, we report a case of
a 68-year-old man who presented with hematuria and was found to have
an enlarged neck mass and a huge mass at the left kidney. Radical neph-
roureterectomy with bladder cuff excision and paraaortic lymphadenec-
tomy was performed. A diagnosis of primary large cell neuroendocrine
carcinoma with coexisting high-grade urothelial components was
rendered. Besides, the ﬁne-needle aspiration cytology reported neuroen-
docrine metastasis. In this report, the clinical, cytological, histological, and
immunohistochemical features of this case are described, and a review of
the literature about this neoplasm is presented.
NDP026:
MALIGNANT GLOMUS TUMOR OF KIDNEY e A CASE REPORT
Gu-Shun Lai 1, Kun-Yuan Chiu 1, Siu-Wan Hung 2, John Wang 3. 1Division of
Urology, Department of Surgery, Taichung Veterans General Hospital,
Taichung, Taiwan; 2Department of Radiation, Taichung Veterans General
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Purpose: Glomus tumors are mesenchymal neoplasms that resemble
normal glomus body. Glomus tumors most often occurred in the
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case of malignant glomus tumor arising from kidney.
Case report: A 46 years oldmanwith history of nasopharynx cancer, status
post chemoraiation therapy, has right renal tumor found incidentally on a
pulmonary computed tomography scan for following of nasopharynx
cancer. A contrast enhanced computed tomography of abdomen showed a
tumor about 4.4cm with heterogenous enhancement over medial upper
pole of right kidney. The patient undertook laparoscopic right radical ne-
phrectomy with right adrenalectomy and recovered well after the opera-
tion. According to the histologic and immunohistochemical examination,
the tumor is diagnosed as malignant glomus tumor.
Conclusion: Glomus tumors resemble glomus body, which is associated
with body temperature regulation. Glomus tumors usually occur in the
extremities, most common the subungual region of the ﬁngers. Visceral
organs are uncommon site involving development of glomus tumors.
Glomus tumors arising from kidney are extremely rare, with a few cases
described before.
It is difﬁcult to differentiate glomus tumor from other renal malignany
preoperatively through imaging study. Histolgoy and immunohistochem-
ical study are necessary tomake a diagnosis of glomus tumor of the kidney.
Renal glomus tumors are usually benign with good outcome and prog-
nosis, with one exception of malignant glomus tumor been reported. We
report a case of malignant glomus tumor of kidney. To our knowledge, this
is the second case of malignant renal glomus tumor reported. Given the
small number of cases reported to date and relative short-term follow up,
close clinical follow-up is necessary.
NDP027:
CANCER-TO-CANCER METASTASIS: BREAST CANCER METASTASIZED
INTO RENAL CELL CARCINOMA e A CASE REPORT
Wei-Min Tsai. Divisions of Urology, Department of Surgery, Mennonite
Christian Hospital, Hualien, Taiwan
A 42-year-old female patient, a case of left breast mass with skin ulceration
diagnosed by biopsy, was accidentally found to have right renal mass on CT
(computerized tomography) during cancer staging workup. Metastases to
axillary lymph nodes, bone and liver were also noted at the same time.
Second opinion was sought from Urologist for the right renal mass while
she underwent CCRT (combined chemo-radiotherapy). Biopsy of right
renal mass revealed renal cell carcinoma (RCC) and radical nephrectomy
was done 2 months after initial CCRT. Staging for the RCC was T1aN0M0
while breast cancer stage was T4N1M1.
There are 7 cases (including the current case) reported to have breast
cancer metastasized into RCC. Their ages range from 42e75. Four of them
have RCC on the same side as their breast cancers. Two of the cases are
found only after autopsy. Time lapse in diagnosis of RCC after breast cancer
is from one month to 30 years.
Less than 50 documented cases of cancer-to-cancer metastasis have been
reported. RCC is the most common tumor found to coexist with other
malignancies and is the recipient tumor in cancer-to-cancer metastasis in
65e75% of the reported cases. Because of the “terminal stages” when
kidneys are involved in breast cancer patients, RCC may be under-
diagnosed in these patients and cancer-to-cancer metastasis might be
much more frequent.
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UNUSUAL PRESENTATION OF DIRECT INTRA-PERITONEAL METASTASES
COMPLICATED WITH MASSIVE ASCITES FROM POOR DIFFERENTIATION
BLADDER TUMOR: A CASE REPORT
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Purpose: Plasmacytoid urothelial carcinoma variant is a rare histological
ﬁnding, which was ﬁrst described in 1991. Since then, only 70 cases have
been described in the literature and the biological behavior of this variantof urothelial carcinoma is still not well known. The plasmacytoid variant is
usually very aggressive; distant metastases are detected in up to 60 % of
cases at the time of diagnosis with special predilection for dissemination
through the fascia causing peritoneal carcinomatosis. Despite being a tu-
mor of poor prognosis, it has been shown to be chemosensitive. This report
describes a patient who have adenocarcinoma of colon and plasmacytoid
urothelial carcinoma variant of bladder. Clinically mimicking a massive
ascites and pitting edema of bilateral low legs without hematuria.
Case report: The 74-year-old male suffered from abdominal fullness and
bilateral low legs edema in mid-Aug, 2015. He had visited our GU outpa-
tient department and abdominal sonography was performed which
revealed massive ascites. He was referred to our ER on 2015/08 and
abdomen CT revealed three important ﬁnding (1) massive ascites and
omental cake, (2) Enlarged nodes in the para-aortic space, (3) Diffuse
irregular wall thickening in the urinary bladder, which suspected bladder.
In ER, abdominal paracentesis was done and cytology was collected. After
admission, tumor markers were checked and CEA elevated, so he was
scheduled to receiving colonoscopy and one 3cm colon tumorwas found at
sigmoid colon and several small nodules over whole colon. He also
received cystoscopy and non-papillary type bladder tumor was found.
After colon tumor biopsy and transurethral resection of bladder tumor, we
conﬁrmed that the patient have double cancer. Ascites cytology suggested
malignancy and peritoneal carcinomatosis cannot be rule out. We had used
ascites immunohistochemistry method for search primary tumor. Usually,
we think the origin is form the colon tumor. However, this is not what we
think as a patient. The histological diagnosis of the tumor was plasmacy-
toid urothelial carcinoma variant of bladder with peritoneal metastasis. He
was referred to oncology for further chemotherapy.
Conclusion: The plasmacytoid variant of urothelial carcinoma, deﬁned as
the presence of plasma cells similar to myeloma, has had an increase in
prevalence in recent years, which has aided in increasing our under-
standing of its biological behavior and clinical implications. It is considered
to be a type of carcinoma with an aggressive histological behavior with
special predilection for local invasion of fascia and adjacent tissue. It also
has a poor prognosis with a signiﬁcant percentage of patients having
metastases at diagnosis, especially intraperitoneal dissemination.
NDP029:
SALVAGE HIFU (HIGH-INTENSITY FOCUSED ULTRASOUND) IN THE
MANAGEMENT OF PROSTATE RESIDUAL TUMOR AFTER PRIMARY HIFU
Sharjil Wahid, Guan-Lin Huang, Po Hui Chiang. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Purpose: Recent data on the Ablatherm® HIFU device shows a 5-year
biochemical disease-free survival rate of 80e85%. 15e20% patients have
residual tumor when treated by HIFU for localized prostate cancer. HIFU
can also be used as salvage therapy after radical prostatectomy and
external-beam radiotherapy. There has been little or no literature about
this novel use of secondary HIFU. We present our data of using secondary
HIFU in the management of residual tumor after primary HIFU, with the
aim of determining efﬁcacy and safety of this modality.
Materials and Methods: A total of 168 patients underwent HIFU for pri-
mary treatment of localized prostate cancer from December 2009 to July
2015. 12 patients were offered HIFU as secondary salvage management. All
of these had histologically proven residual/ recurrent prostate cancer after
primary HIFU. 8 were given HIFU as the only management, 3 were given
hormone therapy with HIFU, and 1 received HIFU, hormone therapy and
radiotherapy.
Results: The mean pre-secondary HIFU PSA was 2.28 ng/ml (0.52e4.77).
After salvage HIFU, 8 out of 12 patients (66.7%) achieved nadir PSA less
than 50% of pre-treatment values. These showed biochemical disease free
survival. Mean post-treatment nadir PSA value was 0.39 ng/ml
(0.02e0.75). Time to achieve post-treatment PSA nadir was 1.13 months
(1e2). The 8 patients had mean post-treatment PSA of 0.78 ng/ml
(0.02e1.78) when followed up over a mean period of 11.25 months (1e20),
demonstrating biochemical disease free survival.
3 patients (25%) had elevation of PSA, mean 5.6 ng/ml (3.17e7.52), after
salvage HIFU. These were registered as failures. One patient was excluded
from the study because of negative prostate biopsy, which meant that it
could not be ascertained that the disease was localized or metastatic.
